Superpower partners with GRAIL to offer multi-cancer blood test

Go back to Superpower partners with GRAIL to offer multi-cancer blood test
(NASDAQ: GRAL) Delayed: 60.16 --0 (-0%)
Previous Close $60.16    52 Week High
Open $60.16    52 Week Low
Day High $60.16    P/E N/A 
Day Low $60.16    EPS
Volume 27